Minimally invasive treatment of benign oral vascular lesions: A retrospective study.

IF 2.1 3区医学 Q2 DENTISTRY, ORAL SURGERY & MEDICINE Medicina Oral Patologia Oral Y Cirugia Bucal Pub Date : 2025-03-01 DOI:10.4317/medoral.26809

H-C Silva, A-C Teles, G-F Rocha, E-M Silveira, D-W Douglas-de-Oliveira, A-T Mesquita

{"title":"Minimally invasive treatment of benign oral vascular lesions: A retrospective study.","authors":"H-C Silva, A-C Teles, G-F Rocha, E-M Silveira, D-W Douglas-de-Oliveira, A-T Mesquita","doi":"10.4317/medoral.26809","DOIUrl":null,"url":null,"abstract":"Background: The ethanolamine oleate (EO) in different concentrations has been used in sclerotherapy of oral benign vascular lesions (OBVLs). The aim of the present study was to define demographic and clinical characteristics of patients with OBVLs treated with 5% EO.Material and methods: A retrospective study was conducted of cases treated by sclerotherapy from 1992 to 2022, and medical records of 52 patients with OBVLs were analysed. Thus, 44 cases with complete data were selected and described. Categorical data were analyzed using the chi-square test, with the significance level set at 5% (p < 0.05).Results: Mean age was 52.89 years (range seven to 82 years). The female sex was predominant (77%) and brown was the most common skin color (54%). Most lesions occurred on the lower lip (65.9%), tongue (11.4%), buccal mucosa (9.1%), upper lip (6.8%) and palate (25%.3%). Approximately 73% of the lesions were ≤ 1 cm, > 1 ≤ 2 cm (18.2%,) and > 2 cm (9.1%). Complete regression of the lesions occurred in 97.7% of the cases, with no case of recurrence and no need for complementary surgery. All patients were satisfied with the treatment.Conclusions: Sclerotherapy with 5% EO is a safe and effective method for the treatment of OBVLs.","PeriodicalId":49016,"journal":{"name":"Medicina Oral Patologia Oral Y Cirugia Bucal","volume":" ","pages":"e217-e223"},"PeriodicalIF":2.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11972648/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Oral Patologia Oral Y Cirugia Bucal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4317/medoral.26809","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The ethanolamine oleate (EO) in different concentrations has been used in sclerotherapy of oral benign vascular lesions (OBVLs). The aim of the present study was to define demographic and clinical characteristics of patients with OBVLs treated with 5% EO.

Material and methods: A retrospective study was conducted of cases treated by sclerotherapy from 1992 to 2022, and medical records of 52 patients with OBVLs were analysed. Thus, 44 cases with complete data were selected and described. Categorical data were analyzed using the chi-square test, with the significance level set at 5% (p < 0.05).

Results: Mean age was 52.89 years (range seven to 82 years). The female sex was predominant (77%) and brown was the most common skin color (54%). Most lesions occurred on the lower lip (65.9%), tongue (11.4%), buccal mucosa (9.1%), upper lip (6.8%) and palate (25%.3%). Approximately 73% of the lesions were ≤ 1 cm, > 1 ≤ 2 cm (18.2%,) and > 2 cm (9.1%). Complete regression of the lesions occurred in 97.7% of the cases, with no case of recurrence and no need for complementary surgery. All patients were satisfied with the treatment.

Conclusions: Sclerotherapy with 5% EO is a safe and effective method for the treatment of OBVLs.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

微创治疗口腔良性血管病变的回顾性研究。

背景：不同浓度的油酸乙醇胺（EO）已被用于口腔良性血管病变（OBVLs）的硬化治疗。本研究的目的是确定5% EO治疗的OBVLs患者的人口学和临床特征。材料与方法：回顾性分析1992年至2022年接受硬化治疗的52例OBVLs患者的病历资料。因此，我们选择了44例资料完整的病例进行描述。分类资料采用卡方检验，显著性水平设为5% （p < 0.05）。结果：平均年龄52.89岁（7 ~ 82岁）。女性占多数（77%），棕色是最常见的肤色（54%）。主要病变部位为下唇（65.9%）、舌（11.4%）、颊黏膜（9.1%）、上唇（6.8%）和上颚（25%、3%）。约73%的病变≤1 cm， >≤2 cm (18.2%), > 2 cm（9.1%）。97.7%的病例病灶完全消退，无复发病例，无需补充手术。所有患者均对治疗满意。结论：5% EO硬化治疗OBVLs是一种安全有效的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Medicina Oral Patologia Oral Y Cirugia Bucal DENTISTRY, ORAL SURGERY & MEDICINE-

CiteScore

4.60

自引率

0.00%

发文量

审稿时长

3-8 weeks

期刊介绍： 1. Oral Medicine and Pathology: Clinicopathological as well as medical or surgical management aspects of diseases affecting oral mucosa, salivary glands, maxillary bones, as well as orofacial neurological disorders, and systemic conditions with an impact on the oral cavity. 2. Oral Surgery: Surgical management aspects of diseases affecting oral mucosa, salivary glands, maxillary bones, teeth, implants, oral surgical procedures. Surgical management of diseases affecting head and neck areas. 3. Medically compromised patients in Dentistry: Articles discussing medical problems in Odontology will also be included, with a special focus on the clinico-odontological management of medically compromised patients, and considerations regarding high-risk or disabled patients. 4. Implantology 5. Periodontology